Atlas Trials

NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Clinical trial NCT04658004 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04658004
Sponsor
Zhejiang University
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2021-01-15
Primary completion
2024-01-15
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.